These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32713439)

  • 81. Neoadjuvant therapy for pancreatic cancer: Limitations and advances of response assessment (Review).
    Xu J; Zhan H; Li F; Hu S; Wang L
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649823
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Perioperative chemotherapy with modified FOLFIRINOX for nonmetastatic pancreatic cancer: a new standard of care?
    Radi I; Samaha R; El Hajj J; Samaha H; Kourie HR
    Future Oncol; 2021 Jan; 17(3):229-233. PubMed ID: 33305614
    [No Abstract]   [Full Text] [Related]  

  • 83. Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines.
    Okusaka T; Furuse J
    J Gastroenterol; 2020 Apr; 55(4):369-382. PubMed ID: 31997007
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Microcystic/reticular schwannoma of the pancreas: a potential diagnostic pitfall.
    Liegl B; Bodo K; Martin D; Tsybrovskyy O; Lackner K; Beham A
    Pathol Int; 2011 Feb; 61(2):88-92. PubMed ID: 21255185
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Top Pancreatic Tumor Articles from 2021 to Inform Your Cancer Patients.
    Hogg ME; Melstrom LG
    Ann Surg Oncol; 2023 Jun; 30(6):3437-3443. PubMed ID: 36917337
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Pancreatic cancer].
    Galli R; Schmutz-Kober K; Kühnel J; Maak M; Rosenberg R
    Ther Umsch; 2021; 78(10):605-613. PubMed ID: 34844431
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Neoadjuvant chemo(radio)therapy in upfront resectable pancreatic cancer - can we stratify patients better in the future?
    Andersson R; Tingstedt B
    Scand J Gastroenterol; 2023 Jan; 58(1):1-2. PubMed ID: 35856841
    [No Abstract]   [Full Text] [Related]  

  • 88. [Neoadjuvant treatment of locally advanced pancreatic cancer: outcomes after complete response].
    Schneider M; Büchler MW
    Chirurg; 2021 Oct; 92(10):960. PubMed ID: 34427713
    [No Abstract]   [Full Text] [Related]  

  • 89. CivaSheet intraoperative radiation therapy for pancreatic cancer.
    Taylor RJ; Todor D; Kaplan BJ; Stover W; Fields EC
    Brachytherapy; 2022; 21(2):255-259. PubMed ID: 35031255
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Advanced-stage pancreatic cancer: therapy options.
    Werner J; Combs SE; Springfeld C; Hartwig W; Hackert T; Büchler MW
    Nat Rev Clin Oncol; 2013 Jun; 10(6):323-33. PubMed ID: 23629472
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Call for better response evaluation after neoadjuvant therapy in pancreatic cancer.
    Zaharia C; Søreide K
    Br J Surg; 2023 Feb; 110(3):294-296. PubMed ID: 36630676
    [No Abstract]   [Full Text] [Related]  

  • 92. [Treatment strategy for unresectable locally advanced pancreatic adenocarcinoma].
    Ioka T; Nagano H
    Nihon Shokakibyo Gakkai Zasshi; 2023; 120(8):643-650. PubMed ID: 37558410
    [No Abstract]   [Full Text] [Related]  

  • 93. ASO Author Reflections: Total Neoadjuvant Therapy with Chemotherapy Alone for Pancreatic Cancer?
    Miller PN; Nakakura EK
    Ann Surg Oncol; 2024 Sep; 31(9):6203-6204. PubMed ID: 38909112
    [No Abstract]   [Full Text] [Related]  

  • 94. Neoadjuvant Radiation Therapy Should Still Be Considered in Select Patients With Borderline Resectable Pancreas Cancer.
    Herman JM
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):709. PubMed ID: 37355307
    [No Abstract]   [Full Text] [Related]  

  • 95. ASO Author Reflections: Pancreatic Cancer Having Tumor Contact with an Aberrant Right Hepatic Artery Should be Regarded as Technically Resectable but Oncologically Borderline-Resectable.
    Miura Y; Ohgi K; Sugiura T; Okamura Y; Ashida R; Yamada M; Otsuka S; Yasunaga Y; Nakagawa M; Uesaka K
    Ann Surg Oncol; 2022 Aug; 29(8):4989-4990. PubMed ID: 35445900
    [No Abstract]   [Full Text] [Related]  

  • 96. ASO Author Reflections: Should we Stick our Neck Out for Pancreatic Neck Margins During Pancreaticoduodenectomy After Neoadjuvant Therapy?
    Schachner B; Kelly K; Merchant NB; Datta J
    Ann Surg Oncol; 2022 Sep; 29(9):6013-6014. PubMed ID: 35486265
    [No Abstract]   [Full Text] [Related]  

  • 97. ASO Author Reflections: A Role for Extended VTE Prophylaxis After Neoadjuvant Therapy and Distal Pancreatectomy for Pancreatic Adenocarcinoma.
    Robbins KJ; Hawkins WG
    Ann Surg Oncol; 2024 May; 31(5):2965-2966. PubMed ID: 38214818
    [No Abstract]   [Full Text] [Related]  

  • 98. Multidisciplinary management of locally advanced-borderline resectable adenocarcinoma of the head of the pancreas.
    Calvo F; Guillen Ponce C; Muñoz Beltran M; Sanjuanbenito Dehesa A
    Clin Transl Oncol; 2013 Mar; 15(3):173-81. PubMed ID: 23180346
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Advances in the Surgical Treatment of Pancreatic Cancer.
    Zheng J; Paniccia A; Zureikat AH
    Surg Pathol Clin; 2022 Sep; 15(3):479-490. PubMed ID: 36049830
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Letter to the editor: Understanding surgical attrition for "resectable" pancreatic cancer.
    Brown ZJ; Cloyd JM
    HPB (Oxford); 2024 Apr; 26(4):606-607. PubMed ID: 38246826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.